丹鹿胶囊治疗乳腺增生症的临床疗效观察  被引量:1

Clinical observation of Danlu capsule in the treatment of mammary hyperplasia

在线阅读下载全文

作  者:常晓飞[1] 付丽丽[1] 白骏恒[1] 王鹰 崔猛胜[1] CHANG Xiaofei;FU Lili;BAI Junheng;WANG Ying;CUI Mengsheng(Department of Galactophore,Heping Hospital Affiliated to Changzhi Medical College,Changzhi,Shanxi,046000,China;Department of Traditional Chinese Medicine,Heping Hospital Affiliated to Changzhi Medical College,Changzhi,Shanxi,046000,China)

机构地区:[1]长治医学院附属和平医院乳腺科,山西长治046000 [2]长治医学院附属和平医院中医科,山西长治046000

出  处:《当代医学》2022年第17期132-135,共4页Contemporary Medicine

摘  要:目的探讨丹鹿胶囊治疗乳腺增生症的临床疗效。方法选取2018年10月至2019年5月本院收治的64例乳腺增生患者作为研究对象,均采用丹鹿胶囊治疗,比较治疗前后证候、临床疗效及不良反应。结果主症:治疗后,乳房疼痛、乳房肿块质地、乳房肿块长径分值均低于治疗前,差异有统计学意义(P<0.05)。次症:治疗后,腰膝酸软、神疲乏力、胸胁胀痛、心烦易怒和月经不调发生率均低于治疗前,差异有统计学意义(P<0.05)。治疗后,治愈40例,显效13例,好转10例,无效1例,治疗总有效率为98.4%,不良反应发生率为6.3%。结论丹鹿胶囊治疗乳腺增生患者疗效显著,能有效减轻临床症状,且不良反应少,值得临床推广应用。Objective To explore the clinical efficacy of Danlu capsule in the treatment of mammary hyperplasia.Methods 64 patients with mammary hyperplasia treated in our hospital from October 2018 to May 2019 were selesced as the research subjects,and they were treated with Danlu capsule,the symptoms before and after treatment,clinical efficacy and adverse reactions were compared.Results In terms of main symptoms:after treatment,the breast pain,breast mass texture and breast mass length and diameter scores were lower than those before treatment,and the difference was statistically significant(P<0.05).In terms of secondary symptoms:after treatment,the incidence of waist and knee soreness,mental fatigue,chest and flank pain,irritability and irregular menstruation was lower than that before treatment,and the difference was statistically significant(P<0.05).After treatment,40 cases were cured,13 cases were markedly effective,10 cases were improved,and 1 case was ineffective,the total effective rate was 98.4%,the incidence of adverse reactions was 6.3%.Conclusion Danlu capsule has significant effect on the treatment of mammary hyperplasia can effectively reduce clinical symptoms,with significant clinical efficacy and less adverse reactions,which is worthy of popularization and application.

关 键 词:丹鹿胶囊 乳腺增生症 证候 

分 类 号:R269[医药卫生—中西医结合]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象